Skip to main content
TipRanks
Go Ultimate75% OFF

Nutrien (N7T) AI Stock Analysis

6 Followers
DE:N7T

Nutrien

(XETRA:N7T)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Integrated fertilizer and retail platformThe combination of upstream fertilizer production and downstream retail distribution gives Nutrien multiple ways to serve growers and capture value across the agricultural inputs chain. This integrated model can support product availability, customer reach, volume stability, and margin capture over several quarters.
Negative Factors
Weak free-cash-flow momentum and moderate conversionAlthough cash generation remains positive, the sharp decline in trailing free cash flow and only moderate conversion from net income indicate meaningful sensitivity to reinvestment and working-capital needs. This can constrain funding flexibility and make shareholder returns more dependent on cyclical earnings conditions.

Nutrien (N7T) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%DE:N7T+32.29%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 34.12B
Dividend Yield
2.99%
Average Volume (3M)
246
Price to Earnings (P/E)
15.6
Beta (1Y)
0.24
Revenue Growth
1.54%
EPS Growth
20.75%
Country
Germany
Employees
25,500
Sector
Basic Materials
Sector Strength
61
Industry
Agricultural Inputs

Nutrien Business Overview & Revenue Model

Company Description

Nutrien Ltd. is a prominent agricultural company dedicated to supplying crucial crop inputs and comprehensive services to the farming sector. It specializes in the production and provision of essential plant nutrients like potash, nitrogen, phosphate...

Nutrien Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q3-2026)|% Change Since:1.35%|Next Earnings Date:Feb 17, 2027
Earnings Call SentimentPositive

The call was broadly positive. Nutrien reported strong adjusted EBITDA, a 17% increase in operating cash flow, higher shareholder returns, raised potash and nitrogen volume guidance, operational improvements, and supportive potash and nitrogen market fundamentals. The principal challenges were weaker third-quarter retail performance, Brazil rationalization, elevated sulfur costs and phosphate affordability issues, and supply-chain and geopolitical uncertainty. Management nevertheless presented these issues alongside specific corrective actions and maintained a constructive outlook for 2027.

Positive Updates

Strong Year-to-Date Earnings and Cash Flow
Nutrien generated adjusted EBITDA of $1.31 billion in the third quarter and $4.85 billion through the first nine months of 2026. Cash provided by operating activities increased by 17% through the first nine months compared to the prior year.

Negative Updates

Retail Headwinds from Geopolitical Volatility
Geopolitical-related market volatility contributed to lower crop nutrient sales volumes and higher fuel costs in the retail business, partially offsetting the benefits from higher proprietary products gross margins and a strong livestock market in Australia.

Company Guidance

Nutrien maintained its forecast for global potash shipments of 74 million-77 million tons in 2026 and forecast global potash shipments of 75 million-79 million tons in 2027, raised full-year potash sales volume guidance range to 14.3 million-14.8 million tons and full-year nitrogen sales volume guidance range to 9.3 million-9.7 million tons, expects ammonia operating rates above 95% in the fourth quarter, a moderate increase in fourth-quarter phosphate sales volumes and margins, upstream fertilizer sales volumes to increase by approximately 600,000 tons year-over-year on a like-for-like asset basis, and revised full-year retail adjusted EBITDA guidance range to $1.72 billion-$1.85 billion; it expects mid-single-digit annual growth rates in Retail, mid to high single digits growth for proprietary gross margin on a full-year basis for 2026, stronger North American fall fertilizer application season with a normal fall application window, nitrogen fundamentals to remain tight into 2027, strong demand early in 2027, global potash demand growth in line with historical consumption trends, limited new potash operational capacity in 2027, nitrogen operating rates to reach 91%, potash capacity for 15 million-16 million tons with the ability to get to 19 million tons at $200-$300 a ton in terms of CapEx, and a moderately negative EBITDA contribution from Brazil in 2026.

Nutrien Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:N7T against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
TSE:IFOSTSE:IFOS54NeutralCAD 344.76M13.864.12%―5.77%-86.18%
TSE:KRNTSE:KRN47NeutralCAD 14.39M-18.98-21.18%――28.27%
TSE:NPKTSE:NPK41NeutralCAD 33.30M-2.37-71.66%―-28.84%-18.04%
TSE:MGROTSE:MGRO39UnderperformCAD 27.82M-4.02-218.75%―-54.59%10.76%

* Basic Materials Sector Average

Performance Comparison

0%100%200%300%DE:N7TTSE:KRNTSE:NPKTSE:IFOSTSE:MGRODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:N7T and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:N7TNutrien64.3814.2428.41%
TSE:KRNKarnalyte Resources0.260.14116.67%
TSE:NPKVerde Agritech0.59-0.31-34.44%
TSE:IFOSItafos Inc1.79-1.65-47.97%
TSE:MGROMustgrow Biologics Corp.0.39-0.25-39.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.